WHO backs use of experimental Ebola drugs in West African epidemic
By Kate Kelland and Stephanie Nebehay LONDON/GENEVA (Reuters) – People infected in the West African Ebola outbreak can be offered untested drugs, the World Health Organisation said on Tuesday, but the scarcity of supplies raises questions about who gets priority access to treatment. Liberia said it planned to treat two infected doctors with an unproven Ebola medicine called ZMapp. The outbreak is the world's largest and deadliest and the U.N. agency last week declared it an international health emergency. So far, 1,013 people have died, the vast majority in Guinea, Liberia and Sierra Leone, though two have died in Nigeria.
More From Around the Web
Check out these Articles
- Pfizer weighing sale of Hospira’s pump business: Bloomberg
- Imprimis offers $1 alternative to Turing’s $750 pill
- New implant set to join fight against U.S. painkiller epidemic
- Senate confirms Dr. Robert Califf to lead FDA
- Newly released documents show profit-seeking behind price hikes at Turing, ...
- Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation
- Controversial ‘pay-for-delay’ deals drop after FTC’s win ...
- Medicare patients: Beware of ‘observation’ status in hospitals
- E.ON to name Merck KGaA CEO Kley as supervisory board chairman
- FDA warns India’s Sun Pharma for violating manufacturing standards
- California doctor faces murder trial in 3 men’s drug deaths
- Malaria deaths in Guinea likely to exceed Ebola toll as patients shun clini...
- House opens inquiry into deaths of drug-dependent newborns